Group 1: Market Overview - The U.S. stock market experienced a collective decline among the three major indices, despite reaching historical highs during the trading session [1] - Oppenheimer raised its annual target for the S&P 500 index to 7100 points, indicating an 11% upside potential based on current levels, citing easing trade tensions and steady corporate earnings growth as reasons [3] - The market is closely watching the Federal Reserve's upcoming monetary policy announcement, with expectations that a dovish signal from Powell could significantly impact market sentiment [3] Group 2: Company-Specific Developments - Novo Nordisk's stock plummeted nearly 22% after the company lowered its full-year earnings forecast for the second time this year, primarily due to slower-than-expected growth in the U.S. obesity market and competition from generic drugs and Eli Lilly's Zepbound [3] - Chinese electric vehicle companies, such as Li Auto and Pony.ai, faced declines of 6.14% and 8.52% respectively, influenced by market sentiment and uncertainties in trade policies, although long-term prospects for China's EV sector remain positive [4] Group 3: Trade and Economic Indicators - The U.S. and China agreed to extend the suspension of reciprocal tariffs for 90 days, providing a sense of relief to the market despite the lack of substantial progress in negotiations [5] - Citigroup exited its long position on the euro against the dollar, incurring a loss of $1.3 million, while planning to short the dollar ahead of U.S. employment data, reflecting high volatility in the forex market [5] Group 4: Commodity Market Insights - International oil prices rose approximately 4% for both WTI and Brent crude, driven by U.S. pressure on Russia and supply concerns following an attack in Iran [5] - Gold prices remained stable, likely due to reduced safe-haven demand amid easing trade tensions [5]